PharmSource – Cell Therapy Market Opportunity for CMOs – 2018 Edition
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
This PharmSource Trend Report will explore whether the bio/pharma industry is adequately prepared for future cell therapy developments and whether pharma companies and CDMOs are making appropriate investments in the capacity and technology to support the coming opportunity. In particular, this Trend Report seeks to achieve the following objectives:
a. To describe and evaluate the cell therapy market opportunity;
b. To describe and address the adequacy of the network of CDMOs that manufacture for the cell therapy market, both clinical and commercial;
c. To assess the outlook for buyers and sellers of contract manufacturing services for cell therapies, including the supply/demand balance.
Scope
Who should buy this report?
This 35-page report gives important, expert insight you won’t find in any other source. 16 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
• CMO executives who must have deep understanding of the Cell Therapy marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Pharmaceutical and Biotech companies involved in the development of Cell Therapies or Cell Therapy technologies.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
China PLA General Hospital
GSK
3P Biopharmaceuticals
Abzena
Anemocyte SRL
apceth Biopharma GmbH
Areta International
Army Military Medical University (formerly Third Military Medical University)
Astellas
Atvio Biotech Ltd
Austrianova Singapore Pte. Ltd.
Autolus
Bio Elpida
Bioinova sro
Brammer Bio
CCRM
Celgene
Cell and Gene Therapy Catapult
CellforCure
Cellin Technologies LLC
Cellular Therapeutics Ltd.
Celularity
City of Hope
Cognate Bioservices
Cook General BioTechnology
LLC
Dendreon Pharmaceuticals LLC
Esperite
Fraunhofer Group
GE Healthcare
Gencure
Gilead Sciences Inc.
Histocell SL
Hitachi Chemical Co Ltd
Hitachi Chemical Co.
Ltd.
Holostem Terapie Avanzate
Incell Corporation LLC
International Stem Cell Corporation
Japan Tissue Engineering
Johnson & Johnson
KBI Biopharma
Kite
Kite Pharma Inc.
Lonza Group
Lonza Netherlands
MaSThercell
Medinet
MolMed SpA
New York Blood Center
Inc
Newcastle University
NHS Blood and Transplant
Nikon Corporation
Novartis International AG
Novartis Pharmaceuticals Corp.
Organogenesis Inc.
Oxford Biomedica
Pfizer
Provia Laboratories LLC
Roslin Cell Therapies
Sanpower Group Co Ltd
Sanquin Blood Supply Foundation
Shenzhen Geno-Immune Medical Institute
Stem Cell and Cancer Institute (SCI)
Takara Bio
University College London
University of Edinburgh
University of Miami Health System
University of Minnesota
University of Pittsburgh
University of Utah Health
Vericel Corp.
WuXi AppTec
Yposkesi
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.